RNF112 and glioblastoma: Moreover, the glial-specific marker, GFAP, had increased in differentiated primary GBM cells which stably expressed Znf179 (Fig. 3C,D), suggesting that Znf179 can reprogram GBM cells into a more-differentiated phenotype.